BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SNH-118110 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SNH-118110\, from ClinicalTrials.gov esti
 mates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07649200-2735@assetmemo.bio
DTSTAMP:20261121T005934Z
DTSTART;VALUE=DATE:20270626
DTEND;VALUE=DATE:20270627
SUMMARY:SNH-118110: Phase 1 readout est. (NCT07649200)
DESCRIPTION:SNH-118110\, phase 1.\nStudy: Study of SNH-118110 in Advanced S
 olid Tumors\nEstimated primary completion: 26 June 2027. This is a Clinica
 lTrials.gov estimate\, not a confirmed readout date\, and it can move.\nDr
 ug page: https://assetmemo.bio/drug/snh-118110#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07649200
URL:https://assetmemo.bio/drug/snh-118110#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
